Dafna Capital Management LLC Alkermes Plc. Transaction History
Dafna Capital Management LLC
- $331 Million
- Q1 2025
A detailed history of Dafna Capital Management LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 94,200 shares of ALKS stock, worth $2.76 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
94,200
Previous 120,700
21.96%
Holding current value
$2.76 Million
Previous $3.47 Million
10.4%
% of portfolio
0.94%
Previous 0.94%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$854 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$535 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$346 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$235 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$202 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.82B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...